Male erectile dysfunction. Sexual arousal disorders
Conditions
Interventions
Men over 30 years old with at least 6 months elapsed since their erectile dysfunction and vasculogenic erectile dysfunction.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: Men over 30 years old with at least 6 months elapsed since their erectile dysfunction and vasculogenic erectile dysfunction
Exclusion criteria
Exclusion criteria: Other erectile disorders include neurogenic, psychogenic and idiopathic disorders History of pelvic surgery or radiotherapy Use of anti-coagulants, use of anti-androgen Anatomic penis deformities or prosthesis Total testosterone lower than 8 nmol /dl, Advanced heart or lung disease, neurological or psychiatric illness Pregnant wife International Index of Erectile Dysfunction More Than 25
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased at least 5 points on IIEF Erectile Dysfunction Questionnaire. Timepoint: The case group will be treated with ESWT weekly for 6 weeks. The control group will receive standard drug therapy (tadalafil) during this period. Patients in both groups will be evaluated at baseline, week 10 (4 weeks after treatment) and then every three months to one year. Method of measurement: International Index of Erectile Function Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Score on Erection Hardness Score (EHS) questionnaire to over 3 in men with a lower or equal initial score. Timepoint: At baseline, 10 weeks (4 weeks after treatment) and then every three months to one year. Method of measurement: Erection Hardness Score questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hamed Ghadagami Moghaddam
Mashhad University of Medical Sciences
Outcome results
None listed